Mon, Sep 1, 2014, 8:07 AM EDT - U.S. Markets closed for Labor Day

Recent

% | $
Quotes you view appear here for quick access.

Hyperion Therapeutics, Inc. (HPTX) Message Board

  • rrtzrealmd rrtzrealmd Mar 20, 2013 2:17 PM Flag

    Gotta hate them donut holes...

    ...from HPTX's prospectus:

    Within the Medicare program, as a self-administered drug, Ravicti would be, and BUPHENYL is, reimbursed under the expanded prescription drug benefit, known as Medicare Part D...Historically, Part D beneficiaries have been exposed to significant out-of-pocket costs after they surpass an annual coverage limit and until they reach a catastrophic coverage threshold. However, changes made by recent legislation will reduce this patient coverage gap, known as the donut hole, by transitioning patient responsibility in that coverage range from 100% in 2010 to only 25% in 2020. To help achieve this reduction, beginning in 2011, pharmaceutical manufacturers are required to pay quarterly discounts of 50% off the negotiated price of branded drugs issued to Medicare Part D patients in the donut hole."

    ...oh, man!...a 50% haircut?...gee, that's gotta put a crimp in the old profit margin!...add that to the 23.1%discount Medicaid gets and pretty soon there ain't goin' be no profit margin!...HAW, HAW, HAW!!!...

    Sentiment: Strong Sell

 
HPTX
25.86+0.70(+2.78%)Aug 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Avago Technologies Limited
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT
Criteo SA
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT